High incidence of brain metastases at the time of death in women with metastatic breast cancer treated with trastuzumab.

被引：0
|
作者：
Herrero, A [1 ]
Grandez, R [1 ]
Puertolas, T [1 ]
Orduña, VA [1 ]
Trufero, JM [1 ]
Cid, RP [1 ]
Artal, A [1 ]
Lao, J [1 ]
de Lobera, AR [1 ]
Torres, AA [1 ]
机构：
[1] Hosp Miguel Servet, Zaragoza, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
765
引用
收藏
页码：68S / 68S
页数：1
相关论文
共 50 条
  • [21] Extended survival in women receiving trastuzumab for brain metastases from HER2 positive metastatic breast cancer
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 163 - 163
  • [22] CNS metastases in breast cancer patients treated with trastuzumab
    Globokar, T
    Borstnar, S
    Cufer, T
    Pajk, B
    Cervek, J
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 278 - 279
  • [23] Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
    Mariantonietta Colozza
    Elisa Minenza
    Stefania Gori
    Daniela Fenocchio
    Cristina Paolucci
    Cynthia Aristei
    Piero Floridi
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 1157 - 1159
  • [24] Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab
    Colozza, Mariantonietta
    Minenza, Elisa
    Gori, Stefania
    Fenocchio, Daniela
    Paolucci, Cristina
    Aristei, Cynthia
    Floridi, Piero
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1157 - 1159
  • [25] Brain metastases in patients receiving trastuzumab for breast cancer
    Salmaggi, A.
    Silvani, A.
    Boiardi, A.
    [J]. NEUROLOGICAL SCIENCES, 2007, 28 (01) : 1 - 1
  • [26] Brain metastases in patients receiving trastuzumab for breast cancer
    D. Errante
    D. Bernardi
    A. Bianco
    L. Salvagno
    [J]. Neurological Sciences, 2007, 28 : 52 - 53
  • [27] Fcγ-receptor IIa polymorphism and cardiotoxicity in patients with breast cancer treated with adjuvant trastuzumab.
    Cresti, N.
    Jamieson, D.
    Verrill, M. W.
    Pinkilgton, M.
    Boddy, A. V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Brain metastases in patients receiving trastuzumab for breast cancer
    A. Salmaggi
    A. Silvani
    A. Boiardi
    [J]. Neurological Sciences, 2007, 28 (1) : 1 - 1
  • [29] Meta-analysis of adjuvant trastuzumab for early breast cancer: Cardiotoxicity and brain metastases incidence
    Cuppone, F.
    Bria, E.
    Giannarelli, D.
    Nistico, C.
    Sperduti, I.
    Carlini, P.
    Milella, M.
    Ciccarese, M.
    Cognetti, F.
    Terzoli, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Cost-effectiveness of HER-2 testing strategies to select women with metastatic breast cancer (MBC) for treatment with trastuzumab.
    Oster, G
    Delea, TE
    Berger, A
    Klein, P
    Lieberman, G
    Paton, VE
    Chawla, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 68S - 68S
12345